DDPIC
CVS icon

Deroy & Devereaux Private Investment Counsel’s CVS Health CVS Stock Holding History

Deroy & Devereaux Private Investment Counsel’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.5M Sell
372,011
-9,619
-3% -$859K 1.61% 17
2026
Q1 		$27.4M Sell
381,630
-184
-0% -$14.2K 1.31% 35
2025
Q4 		$30.3M Sell
381,814
-6,020
-2% -$475K 1.47% 27
2025
Q3 		$29.2M Sell
387,834
-3,252
-0.8% -$223K 1.46% 27
2025
Q2 		$27M Sell
391,086
-1,168
-0.3% -$76.6K 1.46% 25
2025
Q1 		$26.6M Sell
392,254
-2,241
-0.6% -$134K 1.54% 25
2024
Q4 		$17.7M Buy
+394,495
New +$22.1M 1.01% 51
2023
Q2 		– Sell
-172,477
Closed -$12.8M – 172
2023
Q1 		$12.8M Sell
172,477
-454
-0.3% -$38.1K 0.97% 53
2022
Q4 		$16.1M Sell
172,931
-261
-0.2% -$25.2K 1.24% 38
2022
Q3 		$16.5M Sell
173,192
-449
-0.3% -$44.4K 1.43% 32
2022
Q2 		$16.1M Buy
173,641
+43,291
+33% +$4.23M 1.33% 40
2022
Q1 		$13.2M Buy
+130,350
New +$13.7M 0.96% 57

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Deroy & Devereaux Private Investment Counsel's CVS Position: Q2 2026 in Review

Deroy & Devereaux Private Investment Counsel reduced its CVS Health (CVS) stake by 2.5% in Q2 2026, selling an estimated $859K and leaving 372,011 shares worth $38.5M. The position accounts for 1.61% of the portfolio, ranked #17.

Deroy & Devereaux Private Investment Counsel first reported a position in CVS in Q1 2022 and has held it in 12 quarters since. 1,467 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Deroy & Devereaux Private Investment Counsel held 372,011 shares of CVS Health worth $38.5M as of Q2 2026.
  • Deroy & Devereaux Private Investment Counsel sold 9,619 CVS Health shares in Q2 2026, an estimated $859K.
  • CVS Health made up 1.61% of Deroy & Devereaux Private Investment Counsel's portfolio in Q2 2026, its #17 holding.
  • Deroy & Devereaux Private Investment Counsel first reported a position in CVS Health in Q1 2022 and has held it in 12 quarters since.
  • 1,467 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Deroy & Devereaux Private Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.